Press Releases
- Novartis Receives Excellence in Community Service Award from the American Red Cross
- June 14, 2007 - What do a big giant blood drop, romance movies and a phone bank have in common? These are some of the unique and creative ways Novartis Vaccines and Diagnostics, Inc. in Emeryville encourages and promotes blood drives within their organization.
more »
- Novartis Receives Health Canada Approval for First Fully Automated Nucleic Acid Testing Solution to Screen for West Nile Virus
- May 15, 2007 - Novartis announced today that Health Canada has approved the PROCLEIX® West Nile Virus (WNV) Assay and the PROCLEIX® TIGRIS® System, the first fully automated Nucleic Acid Testing (NAT) solution to screen for the West Nile virus
more »
- Novartis to market newly approved PROCLEIX® TIGRIS® System in U.S. as the first fully automated system for West Nile virus blood screening
- March 2, 2007 - Novartis announced today that the U.S. Food and Drug Administration (FDA) has cleared the PROCLEIX® TIGRIS® System, the first fully automated nucleic acid testing system, to screen donated blood, organs and tissue for the West Nile virus
more »
- Novartis and American Red Cross Blood Services sign long-term supply agreement for Nucleic Acid Testing products
- June 27, 2006 - Multi-year agreement provides American Red Cross with access to state-of-the-art technology to ensure safety of the US blood supply and prevent spread of diseases
more »
- PROCLEIX® West Nile Virus Assay Receives FDA Approval
- December 1, 2005 - Chiron announced today that the U.S. Food and Drug Administration has approved the PROCLEIX® West Nile Virus Assay to screen whole blood donations for use on the PROCLEIX® System
more »
- Chiron Signs Contract With South Africa National Blood Service
- April 14, 2005 - One million whole blood donations to be screened annually using fully automated PROCLEIX® TIGRIS® System with the PROCLEIX® ULTRIO® Assay
more »
- U.S. Biologics License Application Submitted for PROCLEIX West Nile Virus Assay for Blood Screening
- February 2, 2005 - Gen-Probe and Chiron announced today that a Biologics License Application for the PROCLEIX® West Nile Virus Assay for blood screening has been submitted to the FDA
more »
- Fully Automated PROCLEIX® TIGRIS® System Approved For Use With PROCLEIX® ULTRIO® Assay
- December 13, 2004 - CE Marking Clears Way for Commercialization of the System in European Union and Other Parts of the World
more »
- Chiron and LabCorp Sign Licensing Agreement for Hepatitis C Plasma Testing
- December 3, 2004 - Chiron and Laboratory Corporation of America® Holdings announced today that they have signed a licensing agreement for Chiron's hepatitis C virus intellectual property for nucleic acid testing
more »
- European Regulatory Application Submitted for PROCLEIX® ULTRIO® Assay on Fully Automated TIGRIS® System
- October 19, 2004 - Chiron and Gen-Probe announced that a design dossier amendment for use of the PROCLEIX ULTRIO Assay on the PROCLEIX TIGRIS System has been submitted to Gen-Probe's European notified body
more »
- U.S. Biologics License Application Submitted for PROCLEIX® ULTRIO® Assay For Blood Screening
- September 30, 2004 - Gen-Probe and Chiron announced today that a Biologics License Application for the PROCLEIX ULTRIO Assay for blood screening has been submitted to the FDA
more »
- Testing With PROCLEIX® West Nile Virus Assay Initiated on PROCLEIX® TIGRIS® System Under IND
- September 1, 2004 - Automated System Provides Blood Centers with Highest Process Control for Testing
more »
- Chiron Acquires Prion Solutions Inc.
- August 21, 2004 - Chiron today announced that it had acquired Prion Solutions Inc., a privately held company based in La Jolla, Calif., focused on research into variant Creutzfeldt-Jakob disease (vCJD) and other prion-related diseases
more »
- PROCLEIX® ULTRIO® Study Presented at International Society of Blood Transfusion Conference
- July 14, 2004 - Chiron today announced the results of a multicenter trial of the PROCLEIX ULTRIO Assay presented at a symposium at the International Society of Blood Transfusion (ISBT) meeting in Edinburgh
more »
- PROCLEIX® ULTRIO® Assay Receives European CE Mark
- January 15, 2004 - Chiron Expects to Roll Out Assay in European Economic Area (EEA) Early This Year
more »
- New Test Developed to Screen Donated Blood for West Nile Virus by July 1 Deadline
- June 18, 2003 - Chiron announced today the availability of the PROCLEIX West Nile Virus Assay, the first and only test available to screen donated blood specifically for the West Nile virus
more »
- Important Milestone Reached for West Nile Virus Testing of Donated Blood
- June 13, 2003 - After several cases of transmission of the West Nile virus were linked to blood transfusions last year, the federal government called on makers of blood screening technologies to create a test that could effectively screen donated blood for the virus
more »
- FDA Accepts IND for PROCLEIX® West Nile Virus Assay
- March 25, 2003 - Chiron today announced that the FDA has accepted the investigational new drug application submitted by Chiron's collaborator, Gen-Probe, for an assay to screen blood donations for West Nile virus, a blood-borne pathogen transmitted by mosquitoes
more »
- Chiron Granted U.S. HIV Patent
- March 13, 2003 - Chiron today announced that it has been granted United States Patent No. 6,531,276. This patent is directed to nucleic acid testing (NAT) methods for HIV-1. In addition to its application in screening blood donations, this technology plays an important role in the treatment of HIV-positive patients
more »
- Chiron Signs Multi-Year Agreements with U.S Blood Collection Organizations
- November 19, 2002 - Chiron announced today that multi-year agreements have been signed with the primary blood collection organizations in the US. for supply, service and support of Chiron's PROCLEIX HIV-1/HCV Assay and System
more »
- Chiron Appoints Jack Goldstein President, Chiron Blood Testing
- August 8, 2002 - Chiron today named Jack Goldstein, 55, as president of Chiron's Blood Testing division. Based in Emeryville, Dr. Goldstein will be responsible for the commercial operations of Chiron's blood testing business
more »
- Novartis Vaccines and Diagnostics and Ortho-Clinical Diagnostics Announce Sponsorship of PBS Documentary 'Red Gold: The Epic Story of Blood
- June 20, 2002 - Chiron and Ortho-Clinical Diagnostics, a Johnson & Johnson company, announced today their joint sponsorship of the PBS documentary Red Gold: The Epic Story of Blood. This four-part mini-series will premier on two consecutive Sunday nights, June 23 and 30, 2002
more »
- Chiron's PROCLEIX® HIV-1/HCV Assay Receives FDA Approval
- February 28, 2002 - Chiron today announced that the FDA has approved the PROCLEIX HIV-1/HCV Assay for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV)
more »
- The BLA for the Chiron PROCLEIX® HIV-1/HCV Assay Accepted for Review by the FDA
- December 30, 2001 - Chiron and Gen-Probe announced today that the Biologics License Application for the Chiron PROCLEIX HIV-1/HCV Assay for human immunodeficiency virus type 1 and hepatitis C virus has been accepted for review by the FDA
more »
- Chiron and Roche Agree to Major Diagnostic Licensing Terms
- October 11, 2000 - Chiron licenses HCV and HIV intellectual property for probe-based tests, agrees to limited license for NAT blood screening technology
more »
The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on Novartis' website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.